IU Ventures, established in 2018 and based in Bloomington, Indiana, is the venture capital arm of Indiana University. The organization is dedicated to supporting the entrepreneurial efforts of IU students, faculty, staff, and alumni by facilitating new venture opportunities. IU Ventures focuses on investing in startups and early-stage companies that have connections to the university, fostering innovation and economic growth within the community. Through its initiatives, IU Ventures aims to cultivate a robust ecosystem that encourages the development of new ideas and business ventures emerging from the university's rich intellectual resources.
Chief Venture Officer and Executive Director, Indiana University Angel Network
Jason Whitney
Chief Venture Officer
Past deals in Indiana
Plan Forward
Seed Round in 2023
Plan Forward, LLC is an online platform that focuses on providing dental membership solutions for uninsured patients. Established in 2018 and headquartered in Indianapolis, Indiana, the company partners with dentists and dental practices to create customized in-office membership plans. This platform enables dental providers to offer their services without the complexities of traditional insurance, thereby improving patient access to quality care. Plan Forward's software facilitates the management of membership plans, enhances treatment acceptance, and fosters patient loyalty. It includes features such as pre-built dashboards and compliant membership agreements, making it easier for dental professionals to market their plans and grow their revenue.
Apexian Pharmaceuticals
Venture Round in 2021
Apexian Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Indianapolis, Indiana, focused on developing innovative compounds for cancer treatment. The company's lead product, APX3330, is an oral anticancer agent that targets the APE1/Ref-1 redox protein, a molecule implicated in various cancers, including those affecting the colon, lung, breast, and pancreas. Founded in 2007, Apexian Pharmaceuticals emerged from research conducted by Dr. Mark R. Kelley, which provided insights into the biological mechanisms associated with APE1/Ref-1. In addition to its work in oncology, the company is also exploring treatments for other conditions, such as bladder cancer, sarcomas, age-related macular degeneration, and inflammatory bowel disease. By focusing on the discovery and development of novel pharmaceuticals, Apexian aims to improve patient outcomes through targeted therapies.
Amplified Sciences
Seed Round in 2021
Amplified Sciences LLC is a molecular diagnostics company focused on the early detection of debilitating diseases, particularly pancreatic cancer and kidney disease. Utilizing an ultra-sensitive molecular sensing technology licensed from Purdue University, the company’s platform can detect disease markers at the single molecule level, enabling accurate diagnosis from bodily fluids such as urine and saliva. This versatile technology is designed for scalability to point-of-care applications, allowing for effective disease screening with a favorable cost structure. Amplified Sciences has developed a working prototype and has published proof of concept data, positioning itself to meet significant unmet medical needs in diagnostics. Founded in 2016 and based in West Lafayette, Indiana, the company was previously known as Nutrabiotix.
Encamp
Venture Round in 2021
Encamp, Inc. is a software company that focuses on automating environmental compliance and reporting for organizations in the United States. Founded in 2017 and based in Indianapolis, Indiana, Encamp's software solutions help businesses manage their environmental compliance requirements, track hazardous materials, and streamline reporting processes. One of its key offerings, Tier2, allows organizations to fill out and submit annual reports regarding hazardous chemicals, incorporating detailed information beyond the standard Tier 1 report. Additionally, Encamp provides tools for centralized environmental, health, and safety (EHS) information management, including compliance calendars, task reminders, and a comprehensive form library. Through its innovative technology, Encamp aims to assist businesses in effectively aligning their corporate operations with environmental regulations.
Diagnotes
Venture Round in 2020
Diagnotes, Inc. is a digital healthcare company based in Indianapolis, Indiana, that specializes in enhancing communication and collaboration within the healthcare industry. Established in 2010, the company offers a clinical communication platform designed to facilitate secure messaging, provider scheduling, patient data management, and documentation of discussions. This platform is tailored to the needs of various stakeholders, including patients, physicians, care teams, hospitals, health systems, and physician practices, enabling them to efficiently manage all patient-related communications. Diagnotes' applications are intuitive and easily adopted, serving a diverse clientele that includes large health systems, community hospitals, long-term care facilities, and behavioral health organizations. The platform supports a range of functionalities, from simple messaging to telehealth consultations, ensuring effective communication among healthcare professionals and their patients on a unified, cloud-based system.
Canopy
Seed Round in 2020
Canopy operates an online platform designed for frontline sales managers, providing tools to enhance sales performance and decision-making. The platform offers real-time data insights that help managers identify wins and losses at the individual seller level, enabling proactive coaching and support for sales representatives. By monitoring pipeline and rep data, Canopy alerts leaders to potential issues before they affect deals, thereby improving forecast accuracy and driving strategic change. The platform also highlights performance trends, allowing managers to track team dynamics and diagnose issues effectively. Originally known as Loupe Software, Inc., Canopy was incorporated in 2019 and is headquartered in Indianapolis, Indiana.
Encamp
Series A in 2020
Encamp, Inc. is a software company that focuses on automating environmental compliance and reporting for organizations in the United States. Founded in 2017 and based in Indianapolis, Indiana, Encamp's software solutions help businesses manage their environmental compliance requirements, track hazardous materials, and streamline reporting processes. One of its key offerings, Tier2, allows organizations to fill out and submit annual reports regarding hazardous chemicals, incorporating detailed information beyond the standard Tier 1 report. Additionally, Encamp provides tools for centralized environmental, health, and safety (EHS) information management, including compliance calendars, task reminders, and a comprehensive form library. Through its innovative technology, Encamp aims to assist businesses in effectively aligning their corporate operations with environmental regulations.
Diagnotes
Series A in 2013
Diagnotes, Inc. is a digital healthcare company based in Indianapolis, Indiana, that specializes in enhancing communication and collaboration within the healthcare industry. Established in 2010, the company offers a clinical communication platform designed to facilitate secure messaging, provider scheduling, patient data management, and documentation of discussions. This platform is tailored to the needs of various stakeholders, including patients, physicians, care teams, hospitals, health systems, and physician practices, enabling them to efficiently manage all patient-related communications. Diagnotes' applications are intuitive and easily adopted, serving a diverse clientele that includes large health systems, community hospitals, long-term care facilities, and behavioral health organizations. The platform supports a range of functionalities, from simple messaging to telehealth consultations, ensuring effective communication among healthcare professionals and their patients on a unified, cloud-based system.
Cause.it
Seed Round in 2012
Cause.it Inc. is a company based in Indianapolis, Indiana, founded in 2011, that specializes in developing mobile applications aimed at enhancing engagement between higher education institutions and their alumni. The platform allows schools to connect with alumni by enabling them to create personalized affinity profiles based on their interests. This information helps institutions improve their engagement strategies and tailor fundraising campaigns more effectively. Cause.it seeks to modernize the fundraising landscape by moving away from traditional methods such as direct mail and telemarketing, instead focusing on digital solutions that provide a more streamlined and personalized experience for alumni. Additionally, the application offers tools for community volunteers to sign up for nonprofit service events, thus fostering a deeper connection between volunteers and organizations. Overall, Cause.it aims to simplify a fragmented market and enhance the donor experience through innovative digital tools.
Courseload
Series A in 2012
Courseload, Inc. is an innovative early stage educational software company. Our SaaS offering reduces the cost of most commercially available textbooks and proprietary content by up to 2/3 and provides electronic access to self-generated, open source and fair use educational materials, saving students thousands of dollars over their four year undergraduate careers, while improving both revenue and margin for textbook publishers. Additionally, the Courseload solution offers collaborative teaching and learning capabilities to students and professors that improve learning outcomes as proven by National Science Foundation-sponsored research at a major university. The Courseload solution strongly resonates with those working to make the total cost of college more affordable while enhancing educational results, yielding millions of dollars in aggregate savings to the students of schools each year. Courseload continues its expansion in the higher education and K12 spaces, working with multiple Big Ten schools, private liberal arts and technology universities, community and technical colleges, and the premier K12 school in the State of Indiana. Expansion to other universities, colleges and schools continues
Aarden Pharmaceuticals
Seed Round in 2011
Aarden Pharmaceuticals is a small molecule drug discovery and development company. The company’s novel technology is a chemistry breakthrough that will enable it to make drugs against a previously un-druggable set of intracellular phosphatase (PTP) disease targets. The technology was developed in the laboratory of Dr. Zhong-Yin Zhang, Robert A. Harris Professor and chairman of biochemistry and molecular biology at the Indiana University School of Medicine. Zhang is an internationally recognized expert in the field of protein tyrosine phosphatases (PTPs). Aarden’s first programs are focused on infectious disease, cancer, and metabolic and autoimmune conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.